TY - JOUR
T1 - Undertaking medication review by telehealth
AU - Hanjani, Leila Shafiee
AU - Bell, J. Simon
AU - Freeman, Christopher R.
N1 - Funding Information:
Leila Shafiee Hanjani PharmD, MClinPharm, Centre for Health Services Research, Faculty of Medicine, The University of Queensland, Brisbane, Qld. [email protected] J Simon Bell BPharm (Hons), PhD, MPS, Professor and Director, Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Vic Christopher R Freeman BPharm, GDipClinPharm, PhD, AACPA, AdvPracPharm, FPS, Co-Director, Centre for Optimising Pharmacy Practice-based Excellence in Research, School of Pharmacy, The University of Queensland, Qld; Affiliate Associate Professor, Centre for Health Services Research, Faculty of Medicine, The University of Queensland, Qld Competing interests: JSB reports grants from National Health and Medical Research Council (NHMRC) Boosting Dementia Leadership Fellowship Scheme, Dementia Australia Research Foundation, Victorian Government Department of Health and Human Services, Yulgilbar Foundation, GlaxoSmithKline and various aged care provider organisations, outside of the submitted work. CRF is the National President of the Pharmaceutical Society of Australia (PSA), the recognised peak professional body representing pharmacists in Australia. The PSA is a stakeholder with whom the Government consulted when temporarily permitting the delivery of medication reviews by telehealth. Funding: None. Provenance and peer review: Commissioned, externally peer reviewed.
Publisher Copyright:
© The Royal Australian College of General Practitioners 2020
PY - 2020/12
Y1 - 2020/12
N2 - Background Medication review can be delivered using telehealth during the COVID-19 pandemic to ensure ongoing provision of care to vulnerable patient populations and to minimise risk of infection for both patients and health professionals
AB - Background Medication review can be delivered using telehealth during the COVID-19 pandemic to ensure ongoing provision of care to vulnerable patient populations and to minimise risk of infection for both patients and health professionals
UR - http://www.scopus.com/inward/record.url?scp=85097035854&partnerID=8YFLogxK
U2 - 10.31128/AJGP-06-20-5461
DO - 10.31128/AJGP-06-20-5461
M3 - Article
C2 - 33254216
AN - SCOPUS:85097035854
SN - 2208-794X
VL - 49
SP - 826
EP - 831
JO - Australian Journal of General Practice
JF - Australian Journal of General Practice
IS - 12
ER -